Veropharm to boost net profit 90% in Q1
MOSCOW. July 14 (Interfax) - Russian pharmaceuticals maker Veropharm will post a net profit of $6.9 million in the first quarter of 2010 under International Financial Reporting Standards (IFRS), 90% more than in the same period last year, analysts at investment companies and banks told Interfax in a consensus forecast.
Revenue will rise 26% to $33.9 million, they said.
EBITDA is forecast to increase 80% to $10 million.
Veropharm will publish IFRS results for the first quarter on July 15.
Forecast indicators for Veropharm in Q1 2010 ($ mln):